Is budesonide oral suspension (Eohilia) safe for long-term use?

Budesonide oral suspension (Eohilia) has proven efficacy in the treatment of eosinophilic esophagitis, especially in patients 11 years of age and older. The drug relieves esophageal inflammation and improves symptoms of dysphagia and esophageal discomfort through the local anti-inflammatory effect of budesonide. At the same time, due to its oral suspension dosage form, the drug stays on the esophageal surface for a long time, achieving high local concentration and reducing systemic exposure, so systemic side effects are relatively few.

Long-term useThe safety of Eohilia mainly depends on dose control and treatment course management. Clinical experience shows that when taken regularly according to the recommended dosage and course of treatment, it is well tolerated by patients and the incidence of serious adverse reactions is low. Patients should be regularly monitored for corticosteroid-related reactions during use, such as minor blood sugar fluctuations, blood pressure changes, or local irritation. Pediatric patients should be monitored for height and weight to assess for possible growth deceleration.

In addition,The long-term use of Eohilia needs to be individually adjusted based on the patient's condition. For patients whose symptoms are significantly controlled, the course of treatment can be extended or used intermittently according to medical advice to reduce the risk of long-term corticosteroid exposure. Overseas guidelines point out that oral suspension makes long-term maintenance treatment possible due to its local action characteristics. It is safer than systemic glucocorticoids and is especially suitable for patients who need repeated or long-term control of esophageal inflammation.

In practical applications, patients and medical staff should jointly pay attention to potential adverse reactions, reasonably arrange the medication time and dosage, keep the medication solution evenly shaken and swallowed on time, and follow the regular review and follow-up plan. When used correctly, Eohilia can not only effectively relieve the symptoms of eosinophilic esophagitis, but also maintain safety for a long time, providing patients with a sustainable and stable treatment plan.

Reference materials:https://www.eohilia.com/